Newswise — NORTHFIELD, ILL. — The College of American Pathologists (CAP) Foundation announced today that it has been selected to receive a grant of nearly $95,000 from the Robert Wood Johnson Foundation (RWJF) to evaluate the impact of its See, Test & Treat® cancer screening program on patient engagement and outcomes. Bruce D. Rapkin, PhD, professor of epidemiology and population health, Albert Einstein College of Medicine of Yeshiva University, New York, will be the principal investigator for the study.
See, Test & Treat is a CAP Foundation initiative that delivers free, pathologist-led cervical and breast cancer screening, same-day results, and education to vulnerable communities in the U.S. The goal of the See, Test & Treat program is to engage underserved patients in community health care services by offering same-day screening results and immediate access to follow-up care in a culturally appropriate setting.
As physicians, pathologists know the importance of detecting cancer early when it is most treatable. Pathologists who lead See, Test & Treat coordinate collaborative, multidisciplinary care teams who volunteer and help ensure that patients from low-income, minority, and immigrant communities have access to early cancer detection. See, Test & Treat’s culturally tailored screenings help eliminate the linguistic, financial, social, and cultural barriers to care while empowering women to take charge of their health.
“The Robert Wood Johnson Foundation grant confirms that our work delivering care to at-risk patients, with our unique focus on delivering same-day results and interactive learning, has potential to expand its reach,” said CAP Foundation Board President Lewis Allen Hassell, MD, FCAP. “I’m deeply proud that our aim to engage the underserved patient, introduce her to a clinic, and help her negotiate the health care system, has gained such prestigious support.”
“Communities of Practice” Key to Study
Launch of a “Communities of Practice” resource will be a key component of the RWJF-funded study and will bring together lead pathologists and a multidisciplinary team of care providers from seven See, Test & Treat programs across the U.S.
The “Communities of Practice” members will share insights and best practices for continuous improvement of the program. Moreover, by exploring how the See, Test & Treat model spurs collaborative, coordinated care among health care providers, the group will aim to identify effective new ways to reach the underserved. Pathologist Barbarajean Magnani, PhD, MD, FCAP, will lead the “Communities of Practice.” A pioneering sponsor of See, Test & Treat, Dr. Magnani is the pathologist-in-chief at Tufts Medical Center and a professor of pathology at Tufts University School of Medicine in Boston.
“The See, Test & Treat model connects at-risk patients and their families to critical care when they need it, where they need it,” said RWJF program associate Christine E. Nieves. “This is an opportunity to take a closer look at how community-based models of care can help build a Culture of Health.”
About the College of American Pathologists and the CAP Foundation
As the leading organization with more than 18,000 board-certified pathologists, the College of American Pathologists (CAP) serves patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide. The CAP’s Laboratory Improvement Program, initiated 65 years ago, currently, has customers in more than 100 countries, accrediting 7,600 laboratories and providing proficiency testing to 20,000 laboratories worldwide. Find more information about the CAP at cap.org. Follow CAP on Twitter: @pathologists.
The CAP Foundation, its philanthropic arm, supports patient-centered and humanitarian initiatives led by pathologists, striving to connect people in underserved communities with the specialized skills of pathologists.